Bioinformatics Licensing Pharmacy 
Drug Target Review
JUNE 11, 2025
His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.
The Pharma Data
OCTOBER 27, 2020
License-related fees (5). License-related fees (5). The BREEZE study (NCT03950739) seeks to evaluate 45 patients on a stable dose of Tyvaso after switching to our new dry powder inhaler (DPI) form of treprostinil, which we licensed from MannKind Corporation. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
APRIL 11, 2025
His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.
Drug Target Review
MARCH 13, 2025
His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Explainambiguity: When What You Think Is Not What You Get [Internet].
Drug Target Review
FEBRUARY 11, 2025
Managing this data deluge requires the expertise of multidisciplinary fields like clinical bioinformatics , which bridges statistics, biology and computer science. He also develops and presents customised training programmes (both live and virtual) for companies seeking to improve their in- and out-licensing processes.
Expert insights. Personalized for you.
Let's personalize your content